Litcius/Paper detail

Replicative senescence dictates the emergence of disease-associated microglia and contributes to Aβ pathology

Yanling Hu, Gemma Fryatt, Mohammadmersad Ghorbani, Juliane Obst, David A. Menassa, María Martín‐Estebané, Tim A.O. Muntslag, Adrián Olmos‐Alonso, Monica Guerrero‐Carrasco, Daniel Thomas, Mark S. Cragg, Diego Gómez‐Nicola

2021Cell Reports318 citationsDOIOpen Access PDF

Abstract

The sustained proliferation of microglia is a key hallmark of Alzheimer's disease (AD), accelerating its progression. Here, we aim to understand the long-term impact of the early and prolonged microglial proliferation observed in AD, hypothesizing that extensive and repeated cycling would engender a distinct transcriptional and phenotypic trajectory. We show that the early and sustained microglial proliferation seen in an AD-like model promotes replicative senescence, characterized by increased βgal activity, a senescence-associated transcriptional signature, and telomere shortening, correlating with the appearance of disease-associated microglia (DAM) and senescent microglial profiles in human post-mortem AD cases. The prevention of early microglial proliferation hinders the development of senescence and DAM, impairing the accumulation of Aβ, as well as associated neuritic and synaptic damage. Overall, our results indicate that excessive microglial proliferation leads to the generation of senescent DAM, which contributes to early Aβ pathology in AD.

Topics & Concepts

MicrogliaSenescenceBiologyDiseaseCellular senescenceCell biologyNeurosciencePathologyImmunologyMedicineInflammationGeneticsPhenotypeGeneNeuroinflammation and Neurodegeneration MechanismsImmune cells in cancerNeurological Disease Mechanisms and Treatments
Replicative senescence dictates the emergence of disease-associated microglia and contributes to Aβ pathology | Litcius